Fatigue is associated with excess mortality in the general population: results from the EPIC-Norfolk study

被引:56
作者
Basu, Neil [1 ]
Yang, Xingzi [1 ]
Luben, Robert N. [2 ,4 ]
Whibley, Daniel [1 ]
Macfarlane, Gary J. [1 ]
Wareham, Nicholas J. [3 ,4 ]
Khaw, Kay-Tee [3 ,4 ]
Myint, Phyo Kyaw [1 ]
机构
[1] Univ Aberdeen, Epidemiol Grp, Inst Appl Hlth Sci, Sch Med & Dent, Foresterhill, Aberdeen AB25 2ZD, Scotland
[2] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeway Res Lab, Cambridge, England
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Clin Gerontol Unit, Cambridge, England
[4] MRC Epidemiol Unit, Cambridge, England
基金
英国医学研究理事会;
关键词
Fatigue; Mortality; Cardiovascular; Cancer; HEART-DISEASE; PRIMARY-CARE; FOLLOW-UP; RISK; MEN; WOMEN; INFLAMMATION; PREVALENCE; COHORT; HORMONE;
D O I
10.1186/s12916-016-0662-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Significant fatigue is a frequent reason for seeking medical advice in the general population. Patients, however, commonly feel their complaint is ignored. This situation may be because clinicians perceive fatigue to be benign, unrelated to traditional biomedical outcomes such as premature mortality. The present study aimed to investigate whether an association between significant fatigue and mortality actually exists, and, if so, to identify potential mechanisms of this association. Methods: A population-based cohort of 18,101 men and women aged 40-79 years who completed a measure of fatigue (Short Form 36 vitality domain, SF36-VT) in addition to providing information on possible confounding factors (age, sex, body mass index, marital status, smoking, education level, alcohol consumption, social class, depression, bodily pain, diabetes, use of beta blockers, physical activity and diet) and mechanisms (haemoglobin, C-reactive protein and thyroid function) were followed up prospectively for up to 20 years. Mortality from all causes, cancer and cardiovascular disease was ascertained using death certification linkage with the UK Office of National Statistics. Results: During 300,322 person years of follow-up (mean 16.6 years), 4397 deaths occurred. After adjusting for confounders, the hazard ratio (HR) for all-cause mortality was 1.40 (95 % confidence interval [CI] 1.25-1.56) for those reporting the highest fatigue (bottom SF36-VT quartile) compared with those reporting the lowest fatigue (top SF36-VT quartile). This significant association was specifically observed for those deaths related to cardiovascular disease (HR 1.45, 95 % CI 1.18-1.78) but not cancer (HR 1.09, 95 % CI 0.90-1.32). Of the considered mechanisms, thyroid function was most notable for attenuating this association. The risk of all-cause mortality, however, remained significant even after considering all putative confounders and mechanisms (HR 1.26, 95 % CI 1.10-1.45). Conclusions: High levels of fatigue are associated with excess mortality in the general population. This commonly dismissed symptom demands greater evaluation and should not automatically be considered benign.
引用
收藏
页数:8
相关论文
共 29 条
[1]   Chronic fatigue syndrome: A review [J].
Afari, N ;
Buchwald, D .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (02) :221-236
[2]  
[Anonymous], 2000, MANUAL INTERPRETATIO
[3]   Stress, inflammation and cardiovascular disease [J].
Black, PH ;
Garbutt, LD .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2002, 52 (01) :1-23
[4]   FATIGUE IN PRIMARY CARE - PREVALENCE, PSYCHIATRIC COMORBIDITY, ILLNESS BEHAVIOR, AND OUTCOME [J].
CATHEBRAS, PJ ;
ROBBINS, JM ;
KIRMAYER, LJ ;
HAYTON, BC .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1992, 7 (03) :276-286
[5]   Prevalence of fatigue in general practice [J].
Cullen, W ;
Kearney, Y ;
Bury, G .
IRISH JOURNAL OF MEDICAL SCIENCE, 2002, 171 (01) :10-12
[6]  
Day N, 1999, BRIT J CANCER, V80, P95
[7]   Identifying Clinically Meaningful Fatigue with the Fatigue Symptom Inventory [J].
Donovan, Kristine A. ;
Jacobsen, Paul B. ;
Small, Brent J. ;
Munster, Pamela N. ;
Andrykowski, Michael A. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2008, 36 (05) :480-487
[8]   Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001 [J].
Gallagher, AM ;
Thomas, JM ;
Hamilton, WT ;
White, PD .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2004, 97 (12) :571-575
[9]   Thyroid hormone and cardiovascular disease [J].
Gomberg-Maitland, M ;
Frishman, WH .
AMERICAN HEART JOURNAL, 1998, 135 (02) :187-196
[10]   Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease [J].
Hansson, GK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) :1685-1695